Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)

Autor: King, Brett, Senna, Maryanne M., Mesinkovska, Natasha A., Lynde, Charles, Zirwas, Matthew, Maari, Catherine, Prajapati, Vimal H., Sapra, Sheetal, Brzewski, Pawel, Osman, Lawrence, Hanna, Sameh, Wiseman, Marni C., Hamilton, Colleen, Cassella, James

Publikováno v: In Journal of the American Academy of Dermatology November 2024 91(5):880-888

Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2).

Autor: Simpson, Eric L.¹ (AUTHOR) simpsone@ohsu.edu, Prajapati, Vimal H.^2,3,4,5,6 (AUTHOR), Leshem, Yael A.^7,8 (AUTHOR), Chovatiya, Raj^9,10 (AUTHOR), de Bruin-Weller, Marjolein S.¹¹ (AUTHOR), Ständer, Sonja¹² (AUTHOR), Pink, Andrew E.¹³ (AUTHOR), Calimlim, Brian M.¹⁴ (AUTHOR), Lee, Wan-Ju¹⁴ (AUTHOR), Teixeira, Henrique¹⁴ (AUTHOR), Ladizinski, Barry¹⁴ (AUTHOR), Hu, Xiaofei¹⁴ (AUTHOR), Yang, Yang¹⁴ (AUTHOR), Liu, Yingyi¹⁴ (AUTHOR), Liu, Meng¹⁴ (AUTHOR), Grada, Ayman¹⁴ (AUTHOR), Platt, Andrew M.¹⁴ (AUTHOR), Silverberg, Jonathan I.¹⁵ (AUTHOR)

Publikováno v: Dermatology & Therapy. May2024, Vol. 14 Issue 5, p1127-1144. 18p.

The burden of palmoplantar pustulosis: A Canadian population-based study of inpatient care, emergency departments, and outpatient clinics

Autor: Tarride, Jean-Eric, Prajapati, Vimal H., Lynde, Charles, Blackhouse, Gord

Publikováno v: In JAAD International September 2023 12:151-159

Efficacy and safety of switching from dupilumab to upadacitinib versus continuous upadacitinib in moderate-to-severe atopic dermatitis: Results from an open-label extension of the phase 3, randomized, controlled trial (Heads Up)

Autor: Blauvelt, Andrew, Ladizinski, Barry, Prajapati, Vimal H., Laquer, Vivian, Fischer, Alison, Eisman, Samantha, Hu, Xiaofei, Wu, Tianshuang, Calimlim, Brian M., Kaplan, Blair, Liu, Yingyi, Teixeira, Henrique D., Liu, John, Eyerich, Kilian

Publikováno v: In Journal of the American Academy of Dermatology September 2023 89(3):478-485

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.